Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics Business Wire Bristol Myers to buy startup Orbital Therapeutics, building out cell therapy pipeline statnews.com BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence Fierce Biotech BMS Makes $1.5B Cell Therapy Play With Orbital Takeover BioSpace Bristol Myers joins in vivo CAR-T race with …
Read More »Tag Archives: acquisition
Spyware maker NSO Group confirms acquisition by US investors
Israeli spyware maker NSO Group has confirmed to TechCrunch that a U.S. investment group has acquired the company. NSO spokesperson Oded Hershowitz told TechCrunch on Friday that “an American investment group has invested tens of millions of dollars in the company and has acquired controlling ownership.” Confirmation of the deal came soon after Israeli tech news website Calcalist reported Friday …
Read More »Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics – Bristol Myers Squibb
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics Bristol Myers SquibbView Full Coverage on Google News Source link
Read More »Bristol Myers joins in vivo CAR-T race with $1.5B Orbital acquisition
Bristol Myers Squibb is delving further into cell therapies with the $1.5 billion cash purchase of Orbital Therapeutics, the New Jersey pharma Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. Source link
Read More »Sony’s Acquisition of Bungie Continues to Be Questioned as Destiny 2 Falls Off a Cliff
Destiny 2, the ongoing live service shooter from Bungie, is seriously struggling to retain players right now. To be fair, the game does have a fairly sizeable DLC coming up in December — you know, the Star Wars one — but at the time of writing this article, there’s some real doom and gloom surrounding Destiny 2 as a whole. …
Read More »Warren Buffett’s Berkshire Hathaway may have scored a ‘genius’ win-win in $10 billion acquisition that could mark the last big deal of his career
The big move by Warren Buffett’s Berkshire Hathaway to buy the chemicals business of oil giant Occidental Petroleum for nearly $10 billion is a double win for Berkshire, analysts say, in Buffett’s potential swan song deal before retiring at the end of December. The Oct. 2 deal is the first-ever Berkshire announcement that quotes incoming CEO Greg Abel and doesn’t …
Read More »IonQ Stock Heads for a Record High. This Acquisition Got Clearance. – Barron's
IonQ Stock Heads for a Record High. This Acquisition Got Clearance. Barron’s UK Clears IonQ Acquisition of Oxford Ionics, With Conditions The Quantum Insider This Artificial Intelligence (AI) Stock Has a First-Mover Advantage in Quantum Integration The Motley Fool IonQ’s Bold Roadmap: Is It the Quantum Stock to Watch in 2025? Nasdaq Why Did IonQ Stock Rocket 16% Today? Stocktwits Source link
Read More »DHL Adds to Healthcare Logistics Services With Acquisition – The Wall Street Journal
DHL Adds to Healthcare Logistics Services With Acquisition The Wall Street Journal DHL Supply Chain Agrees to Acquire SDS Rx Expanding Its Life Sciences and Healthcare Capabilities DHL DHL Supply Chain to acquire SDS Rx DC Velocity DHL Supply Chain says it has agreed to acquire SDS Rx, expand healthcare reach logisticsmgmt.com Source link
Read More »DICK’S Sporting Goods Completes Acquisition of Foot Locker
PITTSBURGH, Sept. 8, 2025 /PRNewswire/ — DICK’S Sporting Goods, Inc. (“DICK’S” or the “Company”) (NYSE: DKS), a leading U.S.-based full-line omni-channel sporting goods retailer, today announced that it has completed its acquisition of Foot Locker, Inc. (“Foot Locker”), a leading footwear and apparel retailer. DICK’S is now positioned to become a global leader in the sports retail industry at the …
Read More »Cas9 senses CRISPR RNA abundance to regulate CRISPR spacer acquisition
Prokaryotes create adaptive immune memories by acquiring foreign DNA snippets, known as spacers, into the CRISPR array1. In type II CRISPR-Cas systems, the RNA-guided effector Cas9 also assists the acquisition machinery by selecting spacers from protospacer adjacent motif (PAM)-flanked DNA2,3. Here, we uncover the first biological role for Cas9 that is independent of its dual RNA partners. Following depletion of …
Read More »